Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Controlled Trial on Extinction of Opioidergic Binge Eating Disorder (BED) With Intranasal Naloxone Administration

NCT01567670 is registered in ClinicalTrials.gov with Lightlake Sinclair Ltd. as lead sponsor.

NCT NCT01567670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01567670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Controlled Trial on Extinction of Opioidergic Binge Eating Disorder (BED) With Intranasal Naloxone Administration
Lead sponsor
Lightlake Sinclair Ltd.
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 31, 2011
Completion date
Not reported
Enrollment
138 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

binge eating disorder